- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05635513
Owlet Smart Sock 3 Accuracy on Infants
Study Overview
Detailed Description
This prospective observational study compared the HR and SpO2 measurements of the OSS3 (Owlet, Utah, USA) with the Masimo SET® (Masimo Corporation, California, USA) in infants admitted to the University of Utah NICU. The inclusion criteria were infants who weighed 1.7-2.5 kg at the time of monitoring and were medically stable to tolerate routine care. The exclusion criteria were: infants with significant anomalies, congenital deformities, or medical instability. Infants with an intravenous catheter (IV) and skin lesions on either foot were excluded from the study. The wireless device being tested was the OSS3. The gold standard for validating the pulse oximeter's accuracy is arterial blood oxygen saturation (SaO 2 ) at the pulse oximeter sensor site. [6] However, obtaining SaO2 is an invasive arterial blood test for infants. To avoid this conflict, the OSS3 was tested against the reference FDA-approved wired pulse oximeter Masimo.
The study was approved by the University of Utah Institutional Review Board, and informed consent was obtained from parents. During the measurement, OSS3 and Masimo were placed on the infants with one device on each foot. Since the data obtained from the study devices can not be recorded in the hospital electronic medical record, the hospital wired pulse oximeter (Philips, Amsterdam, Netherlands) continued to be used on one of the infant's hands during the study period. OSS3 and Masimo were calibrated appropriately against the hospital wired pulse oximeter with matching HR and SpO 2 readings. Pulse oximetry data were collected simultaneously for 60 minutes on the quiet infants. The two devices (OSS3 and Masimo) continuously recorded HR (beats per minute, bpm) and SpO2 (%) every two seconds. Data from the 2 devices were uploaded and compared according to their time stamped measurements. The paired data agreement was compared using Pearson's correlation coefficient (r), Bland-Altman, Average Root Mean Square (ARMS), and Prevalence and Bias Adjusted Kappa (PABAK) analyses.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Utah
-
Salt Lake City, Utah, United States, 84112
- University of Utah NICU
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Infant who weigh between 1.7kg and 2.3kg
- Infant who is admitted to U of U NICU
Exclusion Criteria:
- Infant who has injuries, deformities, abnormalities, or intravenous catheter in the extremities that may prevent proper application of device
- Infant who has unstable vital signs or clinical condition
- No parental consent
- Inability to achieve adequate fit with the OSS3
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Owlet Oxygen Saturation Accuracy Performance
Time Frame: During the monitoring period (approx. 1 hour)
|
Conduct a single-arm observational study to monitor oxygen saturation (SpO2) while a standard wired pulse oximeter (WPOx) will simultaneously evaluate the same parameters in the University of Utah (U of U) Neonatal Intensive Care Unit (NICU).
|
During the monitoring period (approx. 1 hour)
|
|
Owlet Pulse Rate Accuracy Performance
Time Frame: During the monitoring period (approx. 1 hour)
|
Conduct a single-arm observational study to monitor heart rate (HR), while a standard wired pulse oximeter (WPOx) will simultaneously evaluate the same parameters in the University of Utah (U of U) Neonatal Intensive Care Unit (NICU).
|
During the monitoring period (approx. 1 hour)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Belinda Chan, MD, University of Utah
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- OWL NICU 07-2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypoxia Neonatal
-
Sherief Abd-ElsalamRecruiting
-
University Hospital, Strasbourg, FranceRecruitingNeonatal Acidemia and HypoxiaFrance
-
Turku University HospitalRecruitingNeonatal Stroke | Neonatal Hypoxic Ischemic Encephalopathy | Neonatal Encephalopathy, UnspecifiedFinland
-
Christiana Care Health ServicesUniversity of Pennsylvania; Temple University Hospital; Pennsylvania HospitalCompletedBlood Transfusion | Premature | Hypoxia NeonatalUnited States
-
Neonatal Encephalopathy Consortium, JapanNational Cerebral and Cardiovascular Center; Nagoya University; Tokyo Women's... and other collaboratorsUnknownNeonatal Encephalopathy (Neonatal Hypoxic-ischemic Encephalopathy)Japan
-
Hamilton Health Sciences CorporationMcMaster UniversityRecruitingHypoxia-Ischemia, Brain | Hypoxic-Ischemic Encephalopathy | Hypoxia Ischemia, Cerebral | Hypoxia NeonatalCanada
-
Boston Children's HospitalRecruitingNeonatal Encephalopathy | Hypoxic Ischaemic Encephalopathy (HIE)United States
-
Cairo UniversityCompletedNeonatal Hypoxia and AsphyxiaEgypt
-
University of California, San DiegoUniversity of Minnesota; Rady Children's Hospital, San Diego; Middlemore Hospital... and other collaboratorsRecruitingHypoxic-Ischemic Encephalopathy | Neonatal Encephalopathy | Neonatal Seizure | Seizure NewbornUnited States, New Zealand
-
Semmelweis UniversityRecruitingPerinatal Asphyxia | Neonatal Encephalopathy | Neonatal Hypoxic Ischemic Encephalopathy | Hypoxic-Ischaemic EncephalopathyHungary
Clinical Trials on Owlet OSS V3
-
Owlet Baby Care, Inc.University of Utah; Louisiana State University Health Sciences Center Shreveport and other collaboratorsCompletedSkin InjuryUnited States
-
University of Alabama at BirminghamOwlet Baby Care, Inc.CompletedNeonatal Bradycardia | Hypoxemia of NewbornUnited States
-
Owlet Baby Care, Inc.RecruitingHealthyUnited States
-
Owlet Baby Care, Inc.UnknownStress | Pregnancy | AnxietyUnited States
-
Syneron MedicalUnknown
-
University of Alabama at BirminghamOwlet Baby Care, Inc.RecruitingEmergenciesUnited States
-
Owlet Baby Care, Inc.University of California, San FranciscoCompleted
-
Immunitor LLCUnknown
-
Zimmer BiometActive, not recruitingRheumatoid Arthritis | Osteonecrosis | Avascular Necrosis | Rotator Cuff Tears | Proximal Humeral Fracture | Osteoarthritis Shoulder | Rotator Cuff Tear Arthropathy | Rheumatoid Arthritis Shoulder | Revision | Malunion of Fracture, Shoulder RegionFrance
-
Nu-Life SolutionsSuspendedDepression | Chronic Pain | Anxiety | SleeplessnessUnited States